bpc-157 vegf angiogenesis study Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing | Cell and Tissue Research Modulatory effects of BPC 157
Description
10.1016/j.bbrc.2007.05.054 78 GuehringT.WildeG.SumnerM.GrunhagenT.KarneyG
The initial discomfort represents a transition period, not a permanent feature of the protocol
This simplifies formulation but also means the peptide can degrade if storage conditions are poor
IGFBPs are also hypothesised to play a role in glucose metabolism
